Abstract
Mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) approaches 70 - 80%, regardless of the type of pharmacological treatment. Early revascularisation improves survival in AMI with CS. Our aim is to assess the predictors of mid-term outcome after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and CS. Forty-one patients who underwent primary or rescue PCI for CS were analysed comparing their baseline, angiographic, PCI data, 30-day and 1-year survival. There were no significant differences between survivors and non-survivors in baseline characters, except for more number of transfer admissions (P= 0.0005), and cardiopulmonary resuscitations (P= 0.015) in the later group. The mean time between myocardial infarction (MI) onset to shock and MI onset to revascularisation were 12.8 ± 12.9 hours and 17.0 ± 16.8 hours, respectively. Patients with better pre-procedure thrombolysis in myocardial infarction (TIMI) flow in the infarct-related artery (IRA) had better survival (P= 0.0005). Successful PCI was achieved in 48.8% of patients. The 30-day mortality was 56.1% and all were prior to hospital discharge. Patients with successful PCI had better...Continue Reading
References
Mar 11, 1992·Journal of the American College of Cardiology·M D HibbardB J Gersh
Mar 1, 1992·Journal of the American College of Cardiology·G M GaciochE J Topol
Apr 1, 1992·Journal of the American College of Cardiology·A R MoosviS Goldstein
Dec 1, 1988·Circulation·L LeeW W O'Neill
Sep 1, 1973·Circulation·D R AlonsoT Killip
Sep 1, 1995·American Heart Journal·H EltchaninoffP L Whitlow
Mar 1, 1993·American Heart Journal·R C Becker
Feb 14, 1998·Journal of the American College of Cardiology·D AntoniucciP F Fazzini
Apr 1, 1999·European Heart Journal·D HasdaiR M Califf
Apr 15, 1999·The New England Journal of Medicine·R J GoldbergJ M Gore
Jun 26, 1999·European Heart Journal·P UrbanM Pfisterer
Sep 14, 2000·Journal of the American College of Cardiology·J G WebbJ S Hochman
Nov 21, 2000·Lancet·D HasdaiD R Holmes
Feb 22, 2001·QJM : Monthly Journal of the Association of Physicians·C H Davies
Jan 17, 2002·The American Journal of Cardiology·Albert W ChanStephen G Ellis
Mar 29, 2002·The New England Journal of Medicine·Gregg W StoneUNKNOWN Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators
Oct 18, 2003·Journal of the American College of Cardiology·John G WebbUNKNOWN SHOCK Investigators
Feb 16, 2005·Heart·A G C SuttonM A de Belder
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Judith S HochmanUNKNOWN SHOCK Investigators
Nov 12, 2010·Critical Care : the Official Journal of the Critical Care Forum·Matthew E Cove, Graeme MacLaren